Nuwellis (NUWE) EPS (Basic) Growth (1y) (2022 - 2026)
Nuwellis (NUWE) EPS (Basic) Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.44 Bn | 175.14 Bn | 6.27 Bn | -18.87% |
| 2 | Stryker | 128.91 Bn | 126.03 Bn | 3.81 Bn | 13.56% |
| 3 | Medtronic | 108.67 Bn | 99.45 Bn | 6.41 Bn | 18.90% |
| 4 | Boston Scientific | 68.45 Bn | 67.00 Bn | 3.61 Bn | 97.93% |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.59 Bn | 27.48 Bn | 750.30 Mn | 92.23% |
| 7 | GE HealthCare Technologies | 28.53 Bn | 26.24 Bn | 1.98 Bn | -29.95% |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.30 Bn | 2.07 Bn | 114.97% |
| 10 | Nuwellis | 117,386.28 | -1.97 Mn | 1.68 Mn | 92.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 92.44% |
| Dec 31, 2025 | 92.45% |
| Sep 30, 2025 | -99.23% |
| Jun 30, 2025 | 92.30% |
| Mar 31, 2025 | 96.74% |
| Dec 31, 2024 | 99.22% |
| Sep 30, 2024 | 102.74% |
| Jun 30, 2024 | 85.14% |
| Mar 31, 2024 | 89.46% |
| Dec 31, 2023 | 54.45% |
| Sep 30, 2023 | 95.16% |
| Jun 30, 2023 | 91.30% |
| Mar 31, 2023 | 86.82% |
| Dec 31, 2022 | -102.89% |
| Sep 30, 2022 | 63.30% |
| Jun 30, 2022 | 54.70% |
| Mar 31, 2022 | 57.16% |